| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
¶
From the Departments of Psychiatry,*Pathology,and Neurology,¶New York University School of Medicine, New York, New York; the New York State Institute for Basic Research in Developmental Disabilities,Staten Island, New York; and the Departments of Biology and Biochemistry,University of Bath, Bath, United Kingdom
The outbreak of new variant Creutzfeldt-Jakob disease has raised the specter of a potentially large population being at risk to develop this prionosis. None of the prionoses currently have an effective treatment. Recently, vaccination has been shown to be effective in mouse models of another neurodegenerative condition, namely Alzheimer’s disease. Here we report that vaccination with recombinant mouse prion protein delays the onset of prion disease in mice. Vaccination was performed both before peripheral prion exposure and after exposure. A delay in disease onset was seen in both groups, but was more prolonged in animals immunized before exposure. The increase in the incubation period closely correlated with the anti-prion protein antibody titer. This promising finding suggests that a similar approach may work in humans or other mammalian species at risk for prion disease.
Related articles in Am J Pathol:
This article has been cited by other articles:
 |
|
 |
|
  E. Herczenik and M. F. B. G. Gebbink Molecular and cellular aspects of protein misfolding and disease FASEB J, July 1, 2008; 22(7): 2115 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Song, H. Furuoka, C.-L. Kim, M. Ogino, A. Suzuki, R. Hasebe, and M. Horiuchi Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice J. Gen. Virol., June 1, 2008; 89(6): 1533 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Webb, T. Lekishvili, C. Loeschner, S. Sellarajah, F. Prelli, T. Wisniewski, I. H. Gilbert, and D. R. Brown Mechanistic Insights into the Cure of Prion Disease by Novel Antiprion Compounds J. Virol., October 1, 2007; 81(19): 10729 - 10741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kaiser-Schulz, A. Heit, L. Quintanilla-Martinez, F. Hammerschmidt, S. Hess, L. Jennen, H. Rezaei, H. Wagner, and H. M. Schatzl Polylactide-Coglycolide Microspheres CoEncapsulating Recombinant Tandem Prion Protein with CpG-Oligonucleotide Break Self-Tolerance to Prion Protein in Wild-Type Mice and Induce CD4 and CD8 T Cell Responses J. Immunol., September 1, 2007; 179(5): 2797 - 2807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Spinner, R. B. Kascsak, G. LaFauci, H. C. Meeker, X. Ye, M. J. Flory, J. I. Kim, G. B. Schuller-Levis, W. R. Levis, T. Wisniewski, et al. CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils J. Leukoc. Biol., June 1, 2007; 81(6): 1374 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Fernandez-Borges, A. Brun, J. L. Whitton, B. Parra, F. Diaz-San Segundo, F. J. Salguero, J. M. Torres, and F. Rodriguez DNA Vaccination Can Break Immunological Tolerance to PrP in Wild-Type Mice and Attenuates Prion Disease after Intracerebral Challenge. J. Virol., October 1, 2006; 80(20): 9970 - 9976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Trevitt and J. Collinge A systematic review of prion therapeutics in experimental models Brain, September 1, 2006; 129(9): 2241 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gregoire, A. S. Bergot, C. Feraudet, C. Carnaud, P. Aucouturier, and M. B. Rosset The Murine B Cell Repertoire Is Severely Selected against Endogenous Cellular Prion Protein J. Immunol., November 15, 2005; 175(10): 6443 - 6449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Collinge Molecular neurology of prion disease J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 906 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Donofrio, F. L. Heppner, M. Polymenidou, C. Musahl, and A. Aguzzi Paracrine Inhibition of Prion Propagation by Anti-PrP Single-Chain Fv Miniantibodies J. Virol., July 1, 2005; 79(13): 8330 - 8338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Feraudet, N. Morel, S. Simon, H. Volland, Y. Frobert, C. Creminon, D. Vilette, S. Lehmann, and J. Grassi Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells J. Biol. Chem., March 25, 2005; 280(12): 11247 - 11258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Khalili-Shirazi, S. Quaratino, M. Londei, L. Summers, M. Tayebi, A. R. Clarke, S. H. Hawke, G. S. Jackson, and J. Collinge Protein Conformation Significantly Influences Immune Responses to Prion Protein J. Immunol., March 15, 2005; 174(6): 3256 - 3263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Kim, A. Karino, N. Ishiguro, M. Shinagawa, M. Sato, and M. Horiuchi Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation J. Gen. Virol., November 1, 2004; 85(11): 3473 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Polymenidou, F. L. Heppner, E. C. Pellicioli, E. Urich, G. Miele, N. Braun, F. Wopfner, H. M. Schatzl, B. Becher, and A. Aguzzi Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection PNAS, October 5, 2004; 101(suppl_2): 14670 - 14676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ertmer, S. Gilch, S.-W. Yun, E. Flechsig, B. Klebl, M. Stein-Gerlach, M. A. Klein, and H. M. Schatzl The Tyrosine Kinase Inhibitor STI571 Induces Cellular Clearance of PrPSc in Prion-infected Cells J. Biol. Chem., October 1, 2004; 279(40): 41918 - 41927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gregoire, C. Logre, P. Metharom, E. Loing, J. Chomilier, M. B. Rosset, P. Aucouturier, and C. Carnaud Identification of two immunogenic domains of the prion protein--PrP--which activate class II-restricted T cells and elicit antibody responses against the native molecule J. Leukoc. Biol., July 1, 2004; 76(1): 125 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Luhr, E. K. Nordstrom, P. Low, H.-G. Ljunggren, A. Taraboulos, and K. Kristensson Scrapie Protein Degradation by Cysteine Proteases in CD11c+ Dendritic Cells and GT1-1 Neuronal Cells J. Virol., May 1, 2004; 78(9): 4776 - 4782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Rosset, C. Ballerini, S. Gregoire, P. Metharom, C. Carnaud, and P. Aucouturier Breaking Immune Tolerance to the Prion Protein Using Prion Protein Peptides Plus Oligodeoxynucleotide-CpG in Mice J. Immunol., May 1, 2004; 172(9): 5168 - 5174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Sigurdsson, D. R. Brown, M. A. Alim, H. Scholtzova, R. Carp, H. C. Meeker, F. Prelli, B. Frangione, and T. Wisniewski Copper Chelation Delays the Onset of Prion Disease J. Biol. Chem., November 21, 2003; 278(47): 46199 - 46202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gilch, F. Wopfner, I. Renner-Muller, E. Kremmer, C. Bauer, E. Wolf, G. Brem, M. H. Groschup, and H. M. Schatzl Polyclonal Anti-PrP Auto-antibodies Induced with Dimeric PrP Interfere Efficiently with PrPSc Propagation in Prion-infected Cells J. Biol. Chem., May 9, 2003; 278(20): 18524 - 18531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vet. Pathol., November 1, 2002; 39(6): 762 - 763. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
